DeutschNewstral
Article
bizjournals.com on 2019-02-01 20:11
German firm that serves gene therapy biotechs opens Cambridge HQ
Related news
- Headcount soars at Cambridge gene editing biotechs as trials nearbizjournals.com
- Study raises concerns over gene-editing, hitting Cambridge biotechs hardbizjournals.com
- Rockville biotech buys Cambridge gene therapy firm for $86Mbizjournals.com
- Consultant to Cambridge gene therapy firm charged with insider tradingbizjournals.com
- Cambridge gene therapy firm bluebird bio to move to Somervillebizjournals.com
- Trial by fire: Two Cambridge biotechs race to find a gene therapy cure for Duchennebizjournals.com
- Cambridge biotech Sarepta tops $11B market cap on gene therapy databizjournals.com
- Cambridge gene therapy company aims to raise $83M in an IPO next weekbizjournals.com
- Cambridge gene therapy firm loses half of market cap on study resultsbizjournals.com
- After bidding war, Cambridge gene therapy firm Dimension accepts $151M buyoutbizjournals.com
- IRestoring vision by gene therapyinnovations-report.com
Building Europe’s gene therapy ecosystemPolitico.eu- Alexion cuts ties with two Cambridge biotechs in reorganizationbizjournals.com
- Two Cambridge biotechs launch legal battle over trade secretsbizjournals.com
- Cambridge biotechs among big winners at ASH blood disease conferencebizjournals.com
- IHighly specific nucleases for gene targeting and gene therapyinnovations-report.com
- MBayer launches cell and gene therapy platformmarketwatch.com
- BGene-therapy leap restores baby girl's hearingbbc.co.uk
Bayer to purchase gene therapy firmArkansas Online